Mark Wunderlich

18PUBLICATIONS

190CO-AUTHORS

Gene and molecular therapyHaematological tumoursMolecular medicineRegenerative medicine (incl. stem cells)Epigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jun 05, 2026

Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia.

|May 05, 2026

Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

|Dec 06, 2025

Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.

Ke Wang, Shayan Saniei, Nikita Poddar

|Nov 14, 2025

Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.

Tianyi Ling, Cristiana O'Brien, Jonathan R St-Germain

|Aug 01, 2025

ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

Chao Shen, Yuan Che, Keren Zhou

|Dec 20, 2024

Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemia.

Shan Lin, Michael Kotliar, Sushmitha Vallabh

Pageof 3

Frequent Collaborators

Kenneth D Greis

Chiharu Ishikawa

Julie A Reisz

Shan Lin

Angelo D'Alessandro

Lyndsey C Bolanos

Kathleen M Hueneman

Kwangmin Choi

Michael Wyder

John P Perentesis

Frequent Collaborators

Kenneth D Greis

Chiharu Ishikawa

Julie A Reisz

Shan Lin